Post by Augustine Therapeutics

We’re excited to share new data from our efforts to unlock the promise of HDAC6 inhibition in cardiometabolic diseases at the upcoming 2026 Scientific Sessions of the American Diabetes Association® (ADA), taking place in New Orleans, June 5–8, 2026! Learn more here: https://lnkd.in/eWH7JRBk #ADA2026